Revealing RCOR2 as a regulatory component of nuclear speckles.

Authors:
Rivera C; Verbel-Vergara D; Arancibia D; Lappala A; González M and 4 more

Journal:
Epigenetics Chromatin

Publication Year: 2021

DOI:
10.1186/s13072-021-00425-4

PMCID:
PMC8611983

PMID:
34819154

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Epigenetics Chromatin

Abbreviation: Epigenetics Chromatin

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Chromatin accessibility and cell cycle progression are controlled by the HDAC-associated Sin3B prot…
Calderon A; Mestvirishvili T; Boccalatte F and 2 more (2024) - Transparency Score: 3/6
Research progress of SWI/SNF complex in breast cancer.
Li K; Wang B; Hu H. (2024) - Transparency Score: 3/6
Role of sex in immune response and epigenetic mechanisms.
Bhattacharya S; Sadhukhan D; Saraswathy R. (2024) - Transparency Score: 3/6
Altered cfDNA fragmentation profile in hypomethylated regions as diagnostic markers in breast cance…
Wang J; Niu Y; Yang M and 12 more (2023) - Transparency Score: 4/6
Caf1 regulates the histone methyltransferase activity of Ash1 by sensing unmodified histone H3.
Yoon E; Song JJ. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsJ.T.L. is a co-founder of Translate Bio and Fulcrum Therapeutics, and also serves as Advisor to Skyhawk Therapeutics. Competing interests J.T.L. is a co-founder of Translate Bio and Fulcrum Therapeutics, and also serves as Advisor to Skyhawk Therapeutics."

Evidence found in paper:

"Funding This work was supported by the Agencia Nacional de Investigación y Desarrollo (ANID), FONDECYT Regular Grants #1150200, #1191152 to MEA, ANID Ph.D. Fellowships #21161044 to CR, #21212317 to DV and #21150971 to DA, and the National Institutes of Health (N.I.H-R01-HD097665) to J.T.L."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025